ELMIRON (Janssen Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the ELMIRON drug offered from Janssen Pharmaceuticals, Inc.. This Glycosaminoglycan [EPC],Glycosaminoglycans [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Janssen Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: PENTOSAN POLYSULFATE SODIUM
SUBSTANCE NAME: PENTOSAN POLYSULFATE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Glycosaminoglycan [EPC],Glycosaminoglycans [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, GELATIN COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1996-09-26
END MARKETING DATE: 0000-00-00


ELMIRON HUMAN PRESCRIPTION DRUG Details:

Item DescriptionELMIRON from Janssen Pharmaceuticals, Inc.
LABELER NAME: Janssen Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 1996-09-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50458-098_c2e6eea1-81d2-4940-a173-5e454894317d
PRODUCT NDC: 50458-098
APPLICATION NUMBER: NDA020193

Other PENTOSAN POLYSULFATE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthELMIRON
Janssen Pharmaceuticals, Inc.ELMIRON
Physicians Total Care, Inc.Elmiron